Hormone Therapy for Stage 3 Breast Cancer: 59 Real Stories

59 stories match breast cancer, stage 3 and hormone therapy. 48 of them mention surgery.

Kelly, who was diagnosed with Stage III Breast CancerBreast Cancer

Kelly's Stage 3 Breast Cancer Story: “I’m Still Here & THRIVING!"

Patient Info: Kelly Thomas, Female, Under 40 | Stage III

Biomarkers: Initial triple-negative breast cancer; after surgery

As of August 2023, Kelly was 5 years from her Stage IIIC triple-negative breast cancer diagnosis with no recurrence reported.

The Patient Story
OutcomeCancer-Free / NED
Nikki, who was diagnosed with Stage III Inflammatory Breast CancerBreast Cancer

Stage III Inflammatory Breast Cancer: Nikki's Patient Story

Patient Info: Nikki, Female, 40s | Stage III

Biomarkers: Hormone-positive

As of July 2023, Nikki had completed 7 chemotherapy rounds for Stage III inflammatory hormone-positive breast cancer, had no sign of distant spread on PET scans, and was preparing for single mastectomy, radiation, and long-term hormone therapy.

The Patient Story
OutcomeCare Ongoing
Nikki, who was diagnosed with Stage III Inflammatory Breast CancerBreast Cancer

Stage III HER2-Positive Inflammatory Breast Cancer: Nikki's Patient Story

Patient Info: Nikki, Female | Stage III

Biomarkers: HER2-positive; hormone receptor-positive

After 7 chemotherapy rounds, imaging showed no visible disease, but the team expected possible microscopic cancer. A single mastectomy, radiation and long-term hormone therapy were still planned, so she was not classified as cancer-free.

The Patient Story
OutcomeCare Ongoing / Surgery Planned
Neda, who was diagnosed with Stage III Invasive Lobular CarcinomaBreast Cancer

Stage III Invasive Lobular Carcinoma: Neda's Survivor Story

Patient Info: Neda, Female, 40s | Stage III

Neda had completed surgery, 24 CMF treatments and 25 radiation treatments. She was regaining energy, had started endocrine therapy and was preparing to add another recurrence-reduction medicine.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing / Survivorship
Sarah, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Sarah's Patient Story

Patient Info: Sarah, Female, 40s | Stage III

Biomarkers: Estrogen/progesterone-sensitive breast cancer mentioned; exact receptor labels not reported

As of June 2023, Sarah had lived through incurable salivary gland cancer and Stage III breast cancer, completed major breast cancer treatment, paused hormone therapy to pursue IVF under medical guidance, delivered her daughter at 48, and was advocating for people with cancer; no cancer-free or NED status was stated.

The Patient Story
OutcomeCare Ongoing
Sarah, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III HR-Positive Breast Cancer: Sarah's Survivor Story

Patient Info: Sarah McDonald, Female, 40s | Stage III

Biomarkers: ER-positive; PR-positive; HER2-negative

Sarah was 10 years from diagnosis without a recurrence and described the breast cancer as successfully treated. She later paused hormone therapy, completed IVF and gave birth at age 48.

The Patient Story
OutcomeCancer-Free / Long-Term Survivor
Diana, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Diana's Patient Story

Patient Info: Diana, Female, 40s | Stage III

As of 2023, Diana was receiving treatment for Stage III breast cancer after quadrantectomy, chemotherapy, radiation therapy, hormone therapy, unilateral oncological mammoplasty, and lymph-node removal.

Our Cancer Stories
OutcomeCare Ongoing
Jodi, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Jodi's Patient Story

Patient Info: Jodi | Stage III

Jodi remained on tamoxifen after mastectomy for stage 3 breast cancer and had declined the recommended chemotherapy and radiation therapy.

Our Cancer Stories
OutcomeCare Ongoing
Sandra, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Sandra's Patient Story

Patient Info: Sandra Morales, Female, 40s | Stage III

Sandra is doing well, sees her oncologist twice a year, and continues hormone-blocking therapy to reduce recurrence risk.

AACR
OutcomeCare Ongoing
Ada, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Ada's Survivor Story

Patient Info: Ada, Female, 50s | Stage III

Ada described herself as being in remission while continuing hormone therapy. Fear of relapse remained, but she was focusing on travel, healthier routines and time with loved ones.

Our Cancer Stories
OutcomeCancer-Free / Remission
Antonia, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Antonia's Survivor Story

Patient Info: Antonia, Female, Under 40 | Stage III

Antonia described herself as being in remission after multimodal treatment while continuing hormone therapy. Fear of recurrence and metastatic spread remained significant.

Our Cancer Stories
OutcomeCancer-Free / Remission
Edith, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Edith's Patient Story

Patient Info: Edith | Stage III

Edith said her breast cancer was in remission while she continued hormone therapy; she had also begun separate treatment for lymphoma.

Our Cancer Stories
OutcomeCare Ongoing
Karol, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Karol's Patient Story

Patient Info: Karol | Stage III

Karol continued hormone therapy for stage 3 breast cancer after a broader treatment plan including surgery, chemotherapy, and radiation had been recommended.

Our Cancer Stories
OutcomeCare Ongoing
Mujer, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Mujer's Patient Story

Patient Info: Mujer Valiente | Stage III

Mujer Valiente remained on hormone therapy after selecting a multimodal treatment plan for stage 3 breast cancer.

Our Cancer Stories
OutcomeCare Ongoing
Sylvia, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Sylvia's Survivor Story

Patient Info: Sylvia | Stage III

Two years after her November 2022 diagnosis, Sylvia reports being in remission and remains on hormone therapy.

Our Cancer Stories
OutcomeCancer-Free / NED
Carlie, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Carlie's Patient Story

Patient Info: Carlie, Female, 50s | Stage III

As of 2022, Carlie was in remission after double mastectomy, lymphadenectomy, chemotherapy, and radiation therapy, while continuing hormone therapy and managing long-term side effects.

Our Cancer Stories
OutcomeCare Ongoing
Veronica, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Veronica's Patient Story

Patient Info: Veronica | Stage III

Veronica had completed the other parts of her treatment plan and remained on hormone therapy while looking ahead to recovery and returning to work.

Our Cancer Stories
OutcomeCare Ongoing
Carmen, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Carmen's Survivor Story

Patient Info: Carmen, Female, 50s | Stage III

Carmen was declared cancer-free in February 2023 after surgery and follow-up examinations, while continuing hormone therapy and pain medication.

Our Cancer Stories
OutcomeCancer-Free / NED
Yurley, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Yurley's Survivor Story

Patient Info: Yurley, Under 40 | Stage III

She reports that her breast cancer is in remission and that she continues hormone therapy.

Our Cancer Stories
OutcomeCancer-Free / NED
Katie, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Katie's Survivor Story

Patient Info: Katie, Female, Under 40 | Stage III

Biomarkers: Hormone-sensitive breast cancer; specific receptor results not otherwise reported

As of December 2021, Katie had no evidence of cancer at the 5-year treatment mark after Stage III hormone-sensitive breast cancer treatment and later had twins after ovarian function returned.

Cleveland Clinic
OutcomeCancer-Free / NED
Jacque, who was diagnosed with Stage III Invasive Lobular CarcinomaBreast Cancer

Stage III Invasive Lobular Carcinoma: Jacque's Patient Story

Patient Info: Jacque, Female | Stage III

Jacque was treated for Stage III ILC with chemotherapy, 2 lumpectomies, daily radiation, and ongoing Tamoxifen as of December 2021.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing
Martha, who was diagnosed with Stage III Invasive Lobular CarcinomaBreast Cancer

Stage III Invasive Lobular Carcinoma: Martha's Survivor Story

Patient Info: Martha, Female, 40s | Stage III

Martha completed chemotherapy, bilateral mastectomies and 30 radiation treatments and remained on Tamoxifen as part of a planned 10-year course.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing / Survivorship
Angie, who was diagnosed with Stage III Invasive Lobular CarcinomaBreast Cancer

Stage III Invasive Lobular Carcinoma: Angie's Patient Story

Patient Info: Angie, Female | Stage III

Angie completed 4 AC, 12 Taxol, and 30 rounds of radiation for Stage III grade 3 ILC, then continued Arimidex for a planned 10 years as of September 2021.

Lobular Breast Cancer Alliance
OutcomeCare Ongoing